Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Immunology, Immunotherapy : CII|April 27, 2000
Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gammaB A Pulaski, V K Clements, M R Pipeling, et al.Seminars in Cancer Biology|October 1, 1991
Influence of major histocompatibility complex class I, class II and TLA genes on tumor rejectionS Ostrand-Rosenberg, E P Garcia, C A Roby, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory moleculesS Baskar, V K Clements, L H Glimcher, et al.Proceedings of the National Academy of Sciences of the United States of America|June 24, 1997
Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunityT D Armstrong, V K Clements, B K Martin, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Allogeneic H-2 antigen expression is insufficient for tumor rejectionG A Cole, G A Cole, V K Clements, et al.Immunological Reviews|November 24, 1999
Cell-based vaccines for the stimulation of immunity to metastatic cancersS Ostrand-Rosenberg, B A Pulaski, V K Clements, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Single amino acid mutations in the murine MHC class II A beta cytoplasmic domain abrogate antigen presentationT M Laufer, S T Smiley, A Ranger, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Embryonal carcinoma cells express Qa and Tla class I genes of the major histocompatibility complexS Ostrand-Rosenberg, D A Nickerson, V K Clements, et al.Pageof 2